Overview

A Safety and Tolerability Study of Azilsartan Medoxomil in Participants With Essential Hypertension

Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the long term safety and tolerability of azilsartan medoxomil, once daily (QD), in participants with Essential Hypertension.
Phase:
Phase 3
Details
Lead Sponsor:
Takeda
Treatments:
Antihypertensive Agents
Azilsartan medoxomil
Chlorthalidone